Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| BELLICUM PHARMACEUTICALS, INC | 109,873 | reported | 03 Jan 2023 | tx 17+228,083−14,377 |
| CHIMERIX INC | 21,000 | reported | 20 Jun 2019 | tx 7+108,000 |
| HALOZYME THERAPEUTICS, INC. | 20,503 | reported | 14 Aug 2023 | tx 13+96,574−64,700 |
| ACADIA PHARMACEUTICALS INC | 12,148 | reported | 29 May 2026 | tx 43+325,742−207,148 |
| INCYTE CORP | 3,521 | reported | 23 Jun 2015 | tx 125+820,613−721,444 |
| CYTOKINETICS INC | 3,239 | reported | 27 May 2026 | tx 4+34,799 |
| MADRIGAL PHARMACEUTICALS, INC. | 2,627 | reported | 20 Jun 2025 | tx 38+100,940−95,918 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | — | |
| 29 May 2026 | EXERCISE | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 16,004 | 0.00 USD | deriv |
| 29 May 2026 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 9,311 | 0.00 USD | deriv |
| 27 May 2026 | GRANT_AWARD | CYTOKINETICS INC | 2,851 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | CYTOKINETICS INC | 4,301 | 0.00 USD | deriv |
| 15 Jan 2026 | GRANT_AWARD | CYTOKINETICS INC | 197 | 63.44 USD | |
| 10 Nov 2025 | SALE | ACADIA PHARMACEUTICALS INC | 30,000 | 22.37 USD | |
| 19 Aug 2025 | GRANT_AWARD | CYTOKINETICS INC | 27,450 | 0.00 USD | deriv |
| 20 Jun 2025 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 715 | 0.00 USD | |
| 20 Jun 2025 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 1,290 | 0.00 USD | deriv |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | — | |
| 29 May 2025 | EXERCISE | ACADIA PHARMACEUTICALS INC | 9,387 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 13,793 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | ACADIA PHARMACEUTICALS INC | 8,107 | 0.00 USD | deriv |
| 27 Feb 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 770 | 348.94 USD | |
| 27 Feb 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 14,302 | 347.39 USD | |
| 27 Feb 2025 | SALE | MADRIGAL PHARMACEUTICALS, INC. | 398 | 346.90 USD | |
| 27 Feb 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 6,000 | 111.06 USD | |
| 27 Feb 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 9,470 | 65.06 USD | |
| 27 Feb 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 9,470 | 0.00 USD | deriv |
| 27 Feb 2025 | EXERCISE | MADRIGAL PHARMACEUTICALS, INC. | 6,000 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 714 | 0.00 USD | |
| 25 Jun 2024 | GRANT_AWARD | MADRIGAL PHARMACEUTICALS, INC. | 1,105 | 0.00 USD | deriv |
| 29 May 2024 | EXERCISE | ACADIA PHARMACEUTICALS INC | 6,652 | — |